AGM-130

N/A

Report date: 2024/08/09 10:25:44
NME

Base Information

Drug NameAGM-130
Drug Alias NameAGM-130
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCyclin-dependent kinase inhibitors
TargetsCyclin-dependent kinase
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAnygen Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesAnygen Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A